نتائج البحث 501-510 من 13998 لعملية البحث عن alzheimers
A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease. Scottsdale ...
... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.
Biology-based criteria for diagnosis, staging of Alzheimer's disease · Mayo Clinic Q and A: My mom has Alzheimer's. What does that mean for me? Minnesota ...
... Alzheimer's Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants.
Bryan K. Woodruff, M.D.. Neurologist. Phoenix, AZ. مناطق التركيز: Mild cognitive impairment, Dementia, Alzheimer's disease, Frontotemporal dementia, Lewy ...
Neurologist. Rochester, MN. مناطق التركيز: Transient ischemic attack, Stroke, Dementia, Cerebral amyloid angiopathy, Alzheimer's disease, Normal pressure ...
... Alzheimer's disease. A Study Of CGM In GBM. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to compare standard ...
The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.